Corline Biomedical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Henrik Nittmar

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure17.2yrs
CEO ownership2.5%
Management average tenureno data
Board average tenure8.2yrs

Recent management updates

Recent updates

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Aug 24
Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

Mar 15
We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow

Nov 26
We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Jun 22
Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth

Feb 16
We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth

Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth

Jun 14
Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth

Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation

Feb 28
Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation

CEO

Henrik Nittmar (58 yo)

17.2yrs

Tenure

Dr. Henrik Nittmar, Ph. D., has been the Chief Executive Officer of Corline Biomedical AB (publ) (alternate name Corline Systems AB) since 2008. Dr. Nittmar works as an Investment Manager for a select numb...


Board Members

NamePositionTenureCompensationOwnership
Thomas Lifvendahl
Non-Executive Director3.2yrsno datano data
Lars Sunnanväder
Non-Executive Director20.2yrsno data8.62%
SEK 20.0m
Gunilla Ekstrom
Independent Non-Executive Director8.2yrsSEK 105.00kno data
Adam Dahlberg
Chairman20.2yrsno data24.78%
SEK 57.5m
Henrik Krook
Independent Non-Executive Director7.8yrsSEK 105.00kno data
Rutger Ploeg
Scientific Advisor8.2yrsno datano data
Magnus Nilsson
Independent Non-Executive Director5.2yrsno datano data

8.2yrs

Average Tenure

53.5yo

Average Age

Experienced Board: CLBIO's board of directors are considered experienced (8.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/16 02:43
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corline Biomedical AB is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ludvig SvenssonPenser Access
Gustaf MeyerRedeye